121 related articles for article (PubMed ID: 8894146)
1. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study.
Berning B; Kuijk CV; Kuiper JW; Bennink HJ; Kicovic PM; Fauser BC
Bone; 1996 Oct; 19(4):395-9. PubMed ID: 8894146
[TBL] [Abstract][Full Text] [Related]
2. Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.
Reginster JY; Agnusdei D; Gennari C; Kicovic PM
Gynecol Endocrinol; 1999 Oct; 13(5):361-8. PubMed ID: 10599554
[TBL] [Abstract][Full Text] [Related]
3. Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with Tibolone.
Berning B; van Kuijk C; Kuiper JW; Coelingh Bennink HJ; Fauser BC
Maturitas; 1999 Jan; 31(2):151-9. PubMed ID: 10227009
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures.
Pavlov PW; Ginsburg J; Kicovic PM; van der Schaaf DB; Prelevic G; Bennink HJ
Gynecol Endocrinol; 1999 Aug; 13(4):230-7. PubMed ID: 10533157
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of tibolone on bone mineral density in osteoporotic postmenopausal women with previous fractures.
Studd J; Arnala I; Kicovic PM; Zamblera D; Kröger H; Holland N
Obstet Gynecol; 1998 Oct; 92(4 Pt 1):574-9. PubMed ID: 9764631
[TBL] [Abstract][Full Text] [Related]
6. The influence of physical activity on the response of bone mineral density to 5 years tibolone.
Brooke-Wavell K; Prelevic GM; Bartram C; Ginsburg J
Maturitas; 2000 Jun; 35(3):229-35. PubMed ID: 10936739
[TBL] [Abstract][Full Text] [Related]
7. Tibolone: prevention of bone loss in late postmenopausal women.
Bjarnason NH; Bjarnason K; Haarbo J; Rosenquist C; Christiansen C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2419-22. PubMed ID: 8675554
[TBL] [Abstract][Full Text] [Related]
8. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss.
Rymer J; Robinson J; Fogelman I
Osteoporos Int; 2001; 12(6):478-83. PubMed ID: 11446564
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
Gallagher JC; Baylink DJ; Freeman R; McClung M
J Clin Endocrinol Metab; 2001 Oct; 86(10):4717-26. PubMed ID: 11600531
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
11. Tibolone and its effects on bone: a review.
Berning B; Bennink HJ; Fauser BC
Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
Castelo-Branco C; Vicente JJ; Figueras F; Sanjuan A; Martínez de Osaba MJ; Casals E; Pons F; Balasch J; Vanrell JA
Maturitas; 2000 Feb; 34(2):161-8. PubMed ID: 10714911
[TBL] [Abstract][Full Text] [Related]
13. Prevention of post-oophorectomy bone loss with Tibolone.
Lyritis GP; Karpathios S; Basdekis K; Grigoriou O; Katostaras T; Paspati I; Stamatopoulos T; Siampalioti G; Lyritis PG
Maturitas; 1995 Nov; 22(3):247-53. PubMed ID: 8746883
[TBL] [Abstract][Full Text] [Related]
14. Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial.
Beardsworth SA; Kearney CE; Purdie DW
Br J Obstet Gynaecol; 1999 Jul; 106(7):678-83. PubMed ID: 10428524
[TBL] [Abstract][Full Text] [Related]
15. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial.
Jacobsen DE; Melis RJ; Verhaar HJ; Olde Rikkert MG
J Am Med Dir Assoc; 2012 Feb; 13(2):189.e1-7. PubMed ID: 21741883
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal evaluation of the effect of two doses of tibolone on bone density and metabolism in early postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Genazzani AR
Gynecol Endocrinol; 2004 Jan; 18(1):9-16. PubMed ID: 15106359
[TBL] [Abstract][Full Text] [Related]
18. Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
Kasugai Y; Ikegami A; Matsuo K; Ohashi M; Sukamoto T; Hosoi T; Ouchi Y; Orimo H
Bone; 1998 Feb; 22(2):119-24. PubMed ID: 9477234
[TBL] [Abstract][Full Text] [Related]
19. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
[TBL] [Abstract][Full Text] [Related]
20. Tibolone and osteoporosis.
Lazovic G; Radivojevic U; Milosevic V; Lazovic A; Jeremic K; Glisic A
Arch Gynecol Obstet; 2007 Dec; 276(6):577-81. PubMed ID: 17605023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
